Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: Results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882)
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference19 articles.
1. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials;Lancet,2002
2. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas;Hildebrand;Neurology,1994
3. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404;Prados;Int J Radiat Oncol Biol Phys,2004
4. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas;Levin;Clin Cancer Res,2003
5. The biological activity of cisplatin and dibromodulcitol in combination therapy;Jeney;Br J Cancer,1995
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes;International Journal of Radiation Oncology*Biology*Physics;2020-11
2. Predicting survival using the 2016 World Health Organization classification for anaplastic glioma;Clinical Neuropathology;2020-07-01
3. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas;Cancer Research and Treatment;2020-04-23
4. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus;Neuro-Oncology;2019-02-08
5. Central Nervous System Cancers;Absolute Clinical Radiation Oncology Review;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3